Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Neural Transm (Vienna) ; 120(9): 1359-67, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23400363

RESUMEN

In the present study, we investigate the in vitro effect of hypoxanthine on acetylcholinesterase and butyrylcholinesterase activities in the hippocampus, striatum, cerebral cortex and serum of 15-, 30- and 60-day-old rats. Furthermore, we also evaluated the influence of antioxidants, namely α-tocopherol (trolox) and ascorbic acid, and allopurinol to investigate the possible participation of free radicals and uric acid in the effects elicited by hypoxanthine on these parameters. Acetylcholinesterase and butyrylcholinesterase activities were determined according to Ellman et al. (Biochem Pharmacol 7:88-95, 1961), with some modifications. Hypoxanthine (10.0 µM), when added to the incubation medium, enhanced acetylcholinesterase activity in the hippocampus and striatum of 15- and 30-day-old rats and reduced butyrylcholinesterase activity in the serum of 60-day-old rats. The administration of allopurinol and/or antioxidants partially prevented the alterations caused by hypoxanthine in acetylcholinesterase and butyrylcholinesterase activities in the cerebrum and serum of rats. Data indicate that hypoxanthine alters cholinesterase activities, probably through free radicals and uric acid production since the alterations were prevented by the administration of allopurinol and antioxidants. It is presumed that the cholinesterase system may be associated, at least in part, with the neuronal dysfunction observed in patients affected by Lesch-Nyhan disease. In addition, although extrapolation of findings from animal experiments to humans is difficult, it is conceivable that these vitamins and allopurinol might serve as an adjuvant therapy to avoid progression of brain damage in patients affected by this disease.


Asunto(s)
Alopurinol/farmacología , Antioxidantes/farmacología , Colinesterasas/metabolismo , Inhibidores Enzimáticos/farmacología , Hipoxantina/farmacología , Acetilcolinesterasa/metabolismo , Análisis de Varianza , Animales , Ácido Ascórbico/farmacología , Butirilcolinesterasa/metabolismo , Radicales Libres/metabolismo , Hipoxantina/líquido cefalorraquídeo , Síndrome de Lesch-Nyhan/metabolismo , Ratas , Ratas Wistar , Ácido Úrico/metabolismo , alfa-Tocoferol/farmacología
2.
J Neurosurg Sci ; 52(1): 17-21; discussion 21, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18427428

RESUMEN

AIM: The aim of this study was to evaluate the usefulness of cerebral blood flow velocity in the middle cerebral artery measured by transcranial Doppler as criteria to therapeutic action in communicating hydrocephalic children. METHODS: In eight non-tumoral communicating hydrocephalic infants, ranging from five to 18 months of age, monitored from 18 to 36 months (mean time of follow-up: 24.25 months), cerebrospinal fluid (CSF) oxypurines (hypoxanthine and xanthine) and uric acid levels were compared by means of the Evans' index, the mean weekly increase in cranial circumference, and the transcranial Doppler measurements. RESULTS: Results indicate that clinical (mean weekly increase in head circumference), radiological (Evans' index), biochemical (oxypurines and uric acid in the CSF), and hemodynamic (transcranial Doppler) criteria have the same role in monitoring infantile hydrocephalus. CONCLUSION: In conclusion the transcranial Doppler measurement can be done noninvasively and examinations can be repeated when needed, obtaining immediate RESULTS: Hence, it is the most adequate monitoring technique in clinical practice.


Asunto(s)
Hidrocefalia/diagnóstico , Hidrocefalia/terapia , Velocidad del Flujo Sanguíneo , Tamaño Corporal , Circulación Cerebrovascular , Cabeza/patología , Humanos , Hidrocefalia/líquido cefalorraquídeo , Hipoxantina/líquido cefalorraquídeo , Lactante , Ultrasonografía Doppler Transcraneal , Ácido Úrico/líquido cefalorraquídeo , Xantina/líquido cefalorraquídeo
3.
Biol Neonate ; 89(1): 35-41, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16155384

RESUMEN

BACKGROUND: Insufficient cerebral O2 supply leads to cellular energy failure and loss of brain cell function. The relationship between the severity of cellular energy failure due to hemorrhagic hypotension and the loss of electrocortical brain activity (ECBA), as a measure of brain cell function, is not yet fully elucidated in near-term born lambs. OBJECTIVES: To study the relationship between cerebral purine and pyrimidine metabolism, as a measure of brain cell energy failure, and brain cell function after hemorrhagic hypotension in near-term born lambs. METHODS: Eight near-term lambs (term 147 days) were delivered at 131 days of gestation. After a stabilization period, mean arterial blood pressure was reduced till 30% of baseline by withdrawal of blood. Cerebrospinal fluid (CSF) was obtained at the end of the hypotensive period (2.5 h). CSF from 8 siblings was used for comparison. HPLC was used to determine purine and pyrimidine metabolites in CSF, as a measure of cellular energy failure. ECBA was calculated as the root mean square value of a band-filtered (2-16 Hz) one-channel EEG. RESULTS: Values of guanosine, inosine, hypoxanthine, xanthine and uridine were significantly higher, while ECBA was significantly lower after hemorrhagic hypotension than control values. The concentrations of inosine, hypoxanthine, xanthine and uridine were significantly negatively linearly related to ECBA. CONCLUSIONS: Brain cell function is negatively related to concentrations of inosine, hypoxanthine, xanthine and uridine in the CSF after hemorrhagic hypotension in near-term born lambs.


Asunto(s)
Animales Recién Nacidos , Encéfalo/fisiopatología , Hipotensión/veterinaria , Purinas/líquido cefalorraquídeo , Pirimidinas/líquido cefalorraquídeo , Enfermedades de las Ovejas/fisiopatología , Animales , Electroencefalografía , Guanosina/líquido cefalorraquídeo , Hemorragia , Hipotensión/etiología , Hipotensión/fisiopatología , Hipoxantina/líquido cefalorraquídeo , Inosina/líquido cefalorraquídeo , Consumo de Oxígeno , Uridina/líquido cefalorraquídeo , Xantina/líquido cefalorraquídeo
4.
Acta Anaesthesiol Scand ; 47(10): 1287-91, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14616329

RESUMEN

BACKGROUND: Elderly patients with previous organ damage are at risk for minor neurologic deficits after major surgery. Spinal catheter analgesia is used whenever possible in this group and enables regular cerebrospinal fluid (CSF) sampling. Nimodipine, a calcium blocker, may have neuroprotective effects. We examined whether preoperative treatment with nimodipine affects ischemic markers in the CSF during extracranial surgery. METHODS: We performed a prospective, randomized, placebo-controlled, double-blind study in patients (ASA III or IV, 65-85 years) that underwent elective implantation surgery of the hip joint with intrathecal catheter anesthesia. Starting 15 h before surgery, patients received either 30 microg x kg(-1) h(-1) of nimodipine (n = 20) or 0.9% saline solution (placebo, n = 23) as a central venous infusion. The concentrations of neuron-specific enolase, hypoxanthine, creatine-kinase, lactate and pH in the CSF were determined before and immediately after surgery as well as 6 and 24 h after surgery. RESULTS: Before surgery, the baseline CSF pH was normal in all patients. Immediately after surgery it fell significantly to 7.08 +/- 0.29 in the placebo group and non-significantly to 7.27 +/- 0.38 in the treatment group; all values were normalized at 6 and 24 h after surgery in both groups. In the placebo group, lactate levels rose significantly from 1.48 +/- 0.28 mmol l(-1) before surgery to 1.77 +/- 0.27 mmol l(-1) immediately after surgery, and to 2.03 +/- 0.32 mmol l(-1) 24 h after surgery. In the treatment group, lactate concentrations remained stable up to 6 h after surgery (1.55-1.62 mmol l-1), while an increase to 2.10 +/- 0.48 mmol l(-1) was observed 24 h after the operation. Neuron-specific enolase, hypo-xanthine and creatine-kinase showed no change in either group. CONCLUSION: In conclusion, preoperative nimodipine treatment reduced intraoperative CSF acidosis and delayed surgery-related increases in lactate concentration in the CSF by several hours in elderly, comorbid patients at risk for minor postoperative neurologic deficits.


Asunto(s)
Isquemia Encefálica/diagnóstico , Líquido Cefalorraquídeo/química , Complicaciones Intraoperatorias/diagnóstico , Fármacos Neuroprotectores/administración & dosificación , Nimodipina/administración & dosificación , Cuidados Preoperatorios , Anciano , Anciano de 80 o más Años , Anestesia Raquidea , Artroplastia de Reemplazo de Cadera , Biomarcadores/líquido cefalorraquídeo , Isquemia Encefálica/líquido cefalorraquídeo , Isquemia Encefálica/etiología , Bloqueadores de los Canales de Calcio/administración & dosificación , Creatina Quinasa/líquido cefalorraquídeo , Método Doble Ciego , Femenino , Humanos , Concentración de Iones de Hidrógeno , Hipoxantina/líquido cefalorraquídeo , Infusiones Intravenosas , Ácido Láctico/análisis , Masculino , Fosfopiruvato Hidratasa/líquido cefalorraquídeo , Estudios Prospectivos
5.
Pediatr Res ; 52(1): 56-63, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12084848

RESUMEN

The purpose of the study was to investigate the sequence of processes occurring during and after hypoxia-induced acidemia. We used proton nuclear magnetic resonance spectroscopy, which provides an overview of metabolites in cerebrospinal fluid (CSF), reflecting neuronal metabolism and damage. The pathophysiological condition of acute fetal asphyxia was mimicked by reducing maternal uterine blood flow in 14 unanesthetized pregnant ewes. CSF metabolites were measured during hypoxia-induced acidemia, and during the following recovery period, including the periods at 24 and 48 h after the hypoxic insult. Maximum values of the following CSF metabolites were reached during severe hypoxia (pH

Asunto(s)
Acidosis/líquido cefalorraquídeo , Hipoxia/líquido cefalorraquídeo , Espectroscopía de Resonancia Magnética , Ácido 3-Hidroxibutírico/líquido cefalorraquídeo , Animales , Colina/líquido cefalorraquídeo , Ácido Cítrico/líquido cefalorraquídeo , Creatinina/líquido cefalorraquídeo , Metabolismo Energético , Femenino , Glucosa/líquido cefalorraquídeo , Hipoxantina/líquido cefalorraquídeo , Inositol/líquido cefalorraquídeo , Ácido Láctico/líquido cefalorraquídeo , Embarazo , Protones , Ácido Pirúvico/líquido cefalorraquídeo , Ovinos , Ácido Succínico/líquido cefalorraquídeo , Valina/líquido cefalorraquídeo
6.
Neurosci Lett ; 318(2): 65-8, 2002 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-11796187

RESUMEN

The efflux of purine nucleobases and their nucleosides from the rat brain was investigated using the brain efflux index (BEI) method. Calculated BEI values showed that purine nucleobases had very rapid initial efflux after the intracerebral injection, which was followed by the slower efflux due to the intracellular trapping of labelled molecules and confirmed by the capillary depletion technique. The efflux of ribonucleosides was much slower than the efflux of nucleobases and the structure of the sugar moiety seemed to be important, since a significant difference in the efflux velocity between ribo- and deoxyribonucleosides was observed. The results of self- and cross-inhibition studies suggested that the efflux of test molecules was saturable and that purines shared the same transport system on the abluminal side of the blood-brain barrier.


Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Encéfalo/efectos de los fármacos , Proteínas Portadoras/efectos de los fármacos , Nucleósidos de Purina/metabolismo , Purinas/metabolismo , Adenosina/sangre , Adenosina/líquido cefalorraquídeo , Animales , Barrera Hematoencefálica/fisiología , Encéfalo/metabolismo , Radioisótopos de Carbono/metabolismo , Proteínas Portadoras/fisiología , Desoxirribonucleósidos/sangre , Desoxirribonucleósidos/líquido cefalorraquídeo , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/metabolismo , Guanosina/sangre , Guanosina/líquido cefalorraquídeo , Hipoxantina/sangre , Hipoxantina/líquido cefalorraquídeo , Inyecciones Intraventriculares , Inosina/sangre , Inosina/líquido cefalorraquídeo , Nucleósidos de Purina/sangre , Nucleósidos de Purina/líquido cefalorraquídeo , Ratas , Ratas Wistar
7.
Brain Res ; 925(2): 169-75, 2002 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-11792365

RESUMEN

The uptake of principal salvageable nucleobase hypoxanthine was investigated across the basolateral membrane of the sheep choroid plexus (CP) perfused in situ. The results suggest that hypoxanthine uptake was Na+-independent, which means that transport system on the basolateral membrane can mediate the transport in both directions. Although the unlabelled nucleosides adenosine and inosine markedly reduce the transport it seems that this inhibition was due to nucleoside degradation into nucleobases in the cells, since non-metabolised nucleoside analogue NBTI did not inhibit the transport. The presence of adenine also inhibits hypoxanthine uptake while the addition of the pyrimidines does not show any effect, so it seems that the transport of purine nucleobases through basolateral membrane is mediated via a common transporter which is different from the nucleoside transporters. The inclusion of allopurinol in the perfusion fluid did not change the value and general shape of the curve for the uptake which suggest that degradation of hypoxanthine into xanthine and uric acid does not occur in the CP. The capacity of the CP basolateral membrane to transport hypoxanthine is high (90.63+/-3.79 nM/min/g) and close to the values obtained for some essential amino acids by the CP and blood-brain barrier, while the free diffusion is negligible. The derived value of Km (20.72+/-2.42 microM) is higher than the concentration of hypoxanthine in the sheep plasma (15.61+/-2.28 microM) but less than a half of the concentration in the CSF, which indicates that the transport system at basolateral membrane mostly mediates the efflux of hypoxanthine from the cerebrospinal fluid in vivo.


Asunto(s)
Plexo Coroideo/metabolismo , Hipoxantina/metabolismo , Hipoxantina/farmacocinética , Tioinosina/análogos & derivados , Adenina/metabolismo , Alopurinol/farmacología , Animales , Unión Competitiva/efectos de los fármacos , Transporte Biológico/efectos de los fármacos , Transporte Biológico/fisiología , Radioisótopos de Carbono , Plexo Coroideo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Hipoxantina/líquido cefalorraquídeo , Técnicas In Vitro , Manitol/farmacocinética , Perfusión , Ovinos , Sodio/metabolismo , Tioinosina/farmacología , Timina/metabolismo , Tritio , Uracilo/metabolismo , Xantina Oxidasa/antagonistas & inhibidores
8.
J Neurosurg ; 94(5): 782-7, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11354410

RESUMEN

OBJECT: Disturbance of calcium homeostasis contributes to evolving tissue damage and energetic impairment following traumatic brain injury (TBI). Calcium-mediated activation of calcineurin results in production of tissue-damaging nitric oxide and free oxygen radicals. Inhibition of calcineurin induced by the immunosuppressant tacrolimus (FK506) has been shown to reduce structural and functional damage after ischemia. The aims of the present study were to investigate time- and dose-dependent short-term antiedematous effects of tacrolimus following TBI. METHODS: A left temporoparietal contusion (controlled cortical impact injury [CCII]) was induced in 51 male Sprague-Dawley rats. Tacrolimus (1 or 3 mg/kg body weight) was administered by a single intraperitoneal injection at 5 minutes, 30 minutes, or 4 hours after CCII occurred. Control rats received physiological saline. Water contents of traumatized and nontraumatized hemispheres, as well as cerebrospinal fluid (CSF) levels of mediators reflecting tissue damage (the proinflammatory cytokines interleukin [IL]-6 and tumor necrosis factor [TNF]-alpha, the excitotoxin glutamate, and the adenosine triphosphate-degradation product hypoxanthine), were determined 24 hours after trauma. Although CSF levels of IL-6 and TNFalpha were completely suppressed by tacrolimus at all time points and at both concentrations, CSF levels of glutamate and hypoxanthine, as well as edema formation, were only marginally influenced. Significant reduction of cerebral water content was confined to nontraumatized hemispheres. In addition, the higher dose of tacrolimus failed to exert significant antiedematous effects on traumatized hemispheres. CONCLUSIONS: Under the present study design, the potency of tacrolimus in reducing edema formation following CCII seems limited. However, its immunosuppressive effects could be of value in influencing the posttraumatic inflammatory response known to aggravate tissue damage.


Asunto(s)
Lesiones Encefálicas/líquido cefalorraquídeo , Lesiones Encefálicas/tratamiento farmacológico , Inmunosupresores/farmacología , Tacrolimus/farmacología , Agua/metabolismo , Animales , Edema Encefálico/líquido cefalorraquídeo , Edema Encefálico/tratamiento farmacológico , Edema Encefálico/inmunología , Lesiones Encefálicas/inmunología , Calcineurina/metabolismo , Corteza Cerebral/inmunología , Corteza Cerebral/lesiones , Corteza Cerebral/metabolismo , Metabolismo Energético , Ácido Glutámico/líquido cefalorraquídeo , Hipoxantina/líquido cefalorraquídeo , Interleucina-6/líquido cefalorraquídeo , Masculino , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/líquido cefalorraquídeo
9.
J Neurosurg ; 92(5): 853-9, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10794301

RESUMEN

OBJECT: Identification of new therapeutic agents aimed at attenuating posttraumatic brain edema formation remains an unresolved challenge. Among others, activation of bradykinin B2 receptors is known to mediate the formation of brain edema. The purpose of this study was to investigate the protective effect of the novel nonpeptide B2 receptor antagonist, LF 16-0687Ms, in brain-injured rats. METHODS: Focal contusion was produced by controlled cortical impact injury. Five minutes after trauma, the rats received a single dose of no, low- (3 mg/kg body weight), or high- (30 mg/kg) dose LF 16-0687Ms. After 24 hours, the amount of brain swelling and hemispheric water content were determined. Low and high doses of LF 16-0687Ms significantly reduced brain swelling by 25% and 27%, respectively (p < 0.03). Hemispheric water content tended to be increased in the nontraumatized hemisphere. In a subsequent series of 10 rats, cisternal cerebrospinal fluid (CSF) samples were collected to determine whether changes in substances associated with edema formation could clarify why LF 16-0687Ms increases water content. For this, the volume regulator amino acid taurine, the excitatory transmitter glutamate, and the adenosine triphosphate degradation products hypoxanthine and xanthine were measured. In CSF, the levels of taurine, hypoxanthine, and xanthine were significantly decreased following a single administration of LF 16-0687Ms (p < 0.005); the level of glutamate, however, was double that found in control animals (p < 0.05). CONCLUSIONS: Using the present study design, a single administration of LF 16-0687Ms successfully reduced posttraumatic brain swelling. The decreased levels of taurine, hypoxanthine, and xanthine may reflect reduced posttraumatic brain edema, whereas the increased level of glutamate could account for the elevated water content observed in the nontraumatized hemisphere.


Asunto(s)
Antagonistas de los Receptores de Bradiquinina , Edema Encefálico/prevención & control , Lesiones Encefálicas/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Quinolinas/uso terapéutico , Análisis de Varianza , Animales , Agua Corporal/química , Química Encefálica , Edema Encefálico/líquido cefalorraquídeo , Edema Encefálico/metabolismo , Lesiones Encefálicas/líquido cefalorraquídeo , Lesiones Encefálicas/metabolismo , Ácido Glutámico/líquido cefalorraquídeo , Ácido Glutámico/efectos de los fármacos , Hipoxantina/líquido cefalorraquídeo , Inyecciones Subcutáneas , Cininas , Masculino , Fármacos Neuroprotectores/administración & dosificación , Quinolinas/administración & dosificación , Ratas , Ratas Sprague-Dawley , Receptor de Bradiquinina B2 , Taurina/líquido cefalorraquídeo , Taurina/efectos de los fármacos , Xantina/líquido cefalorraquídeo
10.
J Neurotrauma ; 17(12): 1171-8, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11186230

RESUMEN

Modulation of the glutamatergic and excitotoxic pathway may attenuate secondary damage following traumatic brain injury by reducing presynaptic glutamate release and blocking sodium channels in their inactivated state. The aim of the present study was to investigate the neuroprotective potential of riluzole in traumatic brain-injured rats. A left temporoparietal contusion was induced in 70 male Sprague-Dawley rats (controlled cortical impact injury). Riluzole (8 mg/kg body weight) was given 30 min, and 6, 24, and 30 h after trauma, while control rats received physiological saline. Experiments were performed at two different degrees of trauma severity as defined by penetration depth of the impactor rod (1 vs. 1.5 mm) with the aim of investigating impact of severity of tissue damage on the neuroprotective potential of riluzole. At 48 h after trauma, brains were removed to determine hemispheric swelling and water content and to assess cortical contusion volume. Before brain removal cisternal cerebrospinal fluid (CSF) was collected in all rats to determine the effects of riluzole on substances associated with edema formation. For this, the excitatory transmitter glutamate, the volume-regulatory amino acid taurine, and the ATP-degradation product hypoxanthine were analyzed by high-performance liquid chromatography. Overall, the degree of tissue damage seems to influence the neuroprotective potential of riluzole. In rats with a less severe trauma (1-mm penetration depth), hemispheric swelling, cerebral water content of the traumatized hemisphere and cortical contusion volume were significantly reduced under riluzole compared to controls (p < 0.05). In rats with a more severe trauma (1.5-mm penetration depth), the neuroprotective effect of riluzole failed to reach statistical significance. Following trauma, CSF glutamate, taurine, and hypoxanthine levels were significantly increased compared to nontraumatized rats (p < 0.001). However, these neurochemical parameters as measured in cisternal CSF failed to reflect trauma-dependent increases in severity of tissue damage and did not reveal riluzole-mediated neuroprotection. Under the present study design, riluzole significantly reduced brain edema formation and contusion volume in rats subjected to a mild focal cortical contusion.


Asunto(s)
Edema Encefálico/tratamiento farmacológico , Edema Encefálico/patología , Lesiones Encefálicas/tratamiento farmacológico , Lesiones Encefálicas/patología , Corteza Cerebral/lesiones , Fármacos Neuroprotectores/uso terapéutico , Riluzol/uso terapéutico , Animales , Agua Corporal/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Edema Encefálico/metabolismo , Lesiones Encefálicas/líquido cefalorraquídeo , Ácido Glutámico/líquido cefalorraquídeo , Hipoxantina/líquido cefalorraquídeo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Taurina/líquido cefalorraquídeo
12.
Crit Care Med ; 27(7): 1351-7, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10446831

RESUMEN

OBJECTIVES: Brain-injured patients are susceptible to secondary brain damage related to decreased cerebral perfusion pressure associated with edema formation and increased intracranial pressure (ICP). Whenever conventional therapy fails to reduce elevated ICP, barbiturate coma represents an additional intervention that may control ICP. In patients suffering from severe traumatic brain injury, cerebrospinal fluid levels of glutamate, hypoxanthine, and lactate were measured during barbiturate coma and correlated to electroencephalographic recordings and ICP. DESIGN: Prospective, descriptive study. SETTING: Ten-bed surgical intensive care unit in a university hospital. PATIENTS: Twenty-one patients with severe traumatic brain injury (Glasgow Coma Scale score < or = 9); 11 required barbiturate coma because of refractory intracranial hypertension, and 10 were manageable with continuous administration of fentanyl and midazolam. INTERVENTIONS: Thiopental was administered continuously for increased ICP within the first 24 hrs after trauma and adjusted to the burst-suppression pattern (four to six bursts per minute) on continuous electroencephalographic monitoring. MEASUREMENTS AND MAIN RESULTS: Glutamate and hypoxanthine were analyzed using high-performance liquid chromatography, whereas lactate was measured enzymatically. Patients requiring thiopental presented with significantly higher ICP, glutamate, and hypoxanthine levels than patients receiving fentanyl and midazolam (p < .05). Within the first 24 hrs, thiopental significantly reduced cerebrospinal fluid glutamate and hypoxanthine levels in all patients, i.e., the burst-suppression pattern was successfully induced (p < .001). Interestingly, in five patients cerebrospinal fluid glutamate increased to initial values again despite unchanged neuronal activity. In these patients, ICP, hypoxanthine, and lactate remained significantly elevated compared with the six patients with steadily decreasing cerebrospinal fluid glutamate, hypoxanthine, lactate, and ICP values (p < .02). CONCLUSIONS: Barbiturate coma does not unequivocally preserve energetic stability despite successful suppression of neuronal activity. Despite the use of barbiturate coma in patients with refractory intracranial hypertension, persistent release or impaired uptake of glutamate may be associated with continuous anaerobic metabolism, as shown by increases in cerebrospinal fluid hypoxanthine and lactate levels.


Asunto(s)
Lesiones Encefálicas/complicaciones , Ácido Glutámico/líquido cefalorraquídeo , Hipnóticos y Sedantes/uso terapéutico , Hipertensión Intracraneal/tratamiento farmacológico , Tiopental/uso terapéutico , Adolescente , Adulto , Biomarcadores , Electroencefalografía , Femenino , Humanos , Hipoxantina/líquido cefalorraquídeo , Hipertensión Intracraneal/etiología , Hipertensión Intracraneal/fisiopatología , Presión Intracraneal , Ácido Láctico/líquido cefalorraquídeo , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Estadísticas no Paramétricas
13.
Neurosci Lett ; 238(1-2): 25-8, 1997 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-9464646

RESUMEN

Glutamate-mediated excitotoxicity is associated with adenosine triphosphate (ATP) degradation and generation of oxygen radicals. Hypoxanthine and lactate depict energetic impairment, while xanthine and uric acid reflect activity of radical producing xanthine oxidase. Cerebrospinal fluid (CSF) glutamate, hypoxanthine, lactate, xanthine, and uric acid were investigated in neurological patients. In multiple sclerosis, myelopathy, stroke, epilepsy and viral meningitis glutamate, hypoxanthine, xanthine, and uric acid are increased 2-3-fold compared to controls. Lactate is only elevated in meningitis. Normal lactate dehydrogenase (LDH) levels and absent correlation between the albumin ratio and neurochemical parameters exclude an artificial increase due to cell lysis and barrier damage. Absent correlation between neurochemical parameters within each patient group is most likely related to preserved glial and neuronal uptake mechanisms. CSF hypoxanthine, xanthine, and uric acid levels appear superior to lactate in reflecting glutamate-mediated excitotoxicity in neurological patients.


Asunto(s)
Enfermedades del Sistema Nervioso Central/metabolismo , Ácido Glutámico/líquido cefalorraquídeo , Hipoxantina/líquido cefalorraquídeo , Ácido Úrico/líquido cefalorraquídeo , Xantina/líquido cefalorraquídeo , Adulto , Albúminas/líquido cefalorraquídeo , Trastornos Cerebrovasculares/metabolismo , Cromatografía Líquida de Alta Presión , Epilepsia/metabolismo , Femenino , Humanos , L-Lactato Deshidrogenasa/líquido cefalorraquídeo , Ácido Láctico/líquido cefalorraquídeo , Masculino , Meningitis Viral/metabolismo , Persona de Mediana Edad , Esclerosis Múltiple/metabolismo , Albúmina Sérica/análisis , Enfermedades de la Médula Espinal/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...